Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M126,538Revenue $M13,600Net Margin (%)29.8Z-Score17.0
Enterprise Value $M122,540EPS $1.5Operating Margin %38.8F-Score6
P/E(ttm))31.7Cash Flow Per Share $0Pre-tax Margin (%)38.4Higher ROA y-yN
Price/Book21.010-y EBITDA Growth Rate %19.3Quick Ratio1.0Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %17.3Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %7.2ROA % (ttm)38.3Higher Current Ratio y-yN
Dividend Yield %1.7Insider Buy (3m)0ROE % (ttm)69.3Less Shares Outstanding y-yY
Payout Ratio %45.0Shares Outstanding M2,650ROI % (ttm)69.1Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVORuane Cunniff 2014-09-30 Reduce-0.02%$43.9 - $49.03
($46)
$ 47.754%Reduce -52.87%75,642
NVORuane Cunniff 2014-06-30 Reduce-0.02%$42.28 - $46.52
($44.12)
$ 47.758%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 47.7513%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%$32.72 - $36.886
($34.84)
$ 47.7537%Add 58.71%62,194
NVORuane Cunniff 2013-06-30 Buy 0.04%$30.11 - $35.33
($33.29)
$ 47.7543%New holding, 34640 sh.34,640
NVOMario Gabelli 2013-03-31 Reduce$32.24 - $38.86
($34.93)
$ 47.7537%Reduce -60.32%1,734
NVOJohn Hussman 2012-09-30 Sold Out -0.01%$28.83 - $32.15
($30.65)
$ 47.7556%Sold Out0
NVOKen Fisher 2012-06-30 Add1.01%$25.98 - $30.38
($28.44)
$ 47.7568%Add 519.97%2,786,828
NVOJohn Hussman 2012-03-31 Reduce$23.09 - $28.94
($24.82)
$ 47.7592%Reduce -40%3,000
NVOMario Gabelli 2011-12-31 Add$18.92 - $23.05
($21.5)
$ 47.75122%Add 66.87%5,590
NVOJohn Hussman 2011-09-30 Buy 0.01%$19.46 - $25.45
($22.27)
$ 47.75114%New holding, 5000 sh.5,000
NVOKen Fisher 2011-06-30 Add0.06%$23.4 - $26.29
($24.91)
$ 47.7592%Add 68.56%456,434
NVOMario Gabelli 2011-06-30 Reduce$23.4 - $26.29
($24.91)
$ 47.7592%Reduce -21.18%3,350
NVOJohn Keeley 2011-06-30 Sold Out -0.01%$23.4 - $26.29
($24.91)
$ 47.7592%Sold Out0
NVOKen Fisher 2011-03-31 Buy 0.09%$22.16 - $25.59
($23.8)
$ 47.75101%New holding, 270785 sh.270,785
NVOJohn Keeley 2010-12-31 Buy 0.01%$18.2 - $22.43
($20.77)
$ 47.75130%New holding, 2780 sh.2,780
NVOMario Gabelli 2010-09-30 Reduce$16.23 - $19.85
($17.64)
$ 47.75171%Reduce -28.77%4,420
NVOVanguard Health Care Fund 2010-09-30 Sold Out -0.19%$16.23 - $19.85
($17.64)
$ 47.75171%Sold Out0
NVOMario Gabelli 2010-06-30 Reduce$14.8 - $17.06
($15.97)
$ 47.75199%Reduce -56.26%6,205
NVOVanguard Health Care Fund 2010-06-30 Reduce-0.08%$14.8 - $17.06
($15.97)
$ 47.75199%Reduce -42.86%400,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVO Ruane Cunniff 2014-12-3182,19200.02+8.66%
NVO Mario Gabelli 2014-12-316,72000
NVO Tom Gayner 2014-12-311,075,0000.041.2
NVO Ken Fisher 2014-12-3113,039,6480.491.1-2.59%
Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

    Quarterly/Annual Reports about NVO:

      News about NVO:

      Articles On GuruFocus.com
      To Reinvest or Not Reinvest: That is the Question Feb 19 2015 
      Guru Stocks at 52-Week Lows: BABA, NVO, PCLN, ING, EMR Feb 09 2015 
      Examining The Three Largest Guru Portfolios Oct 24 2014 
      Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
      Insider Buys at Halozyme Look to Improve Stock Outlook Sep 18 2014 
      Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
      Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM Sep 02 2014 
      Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM Aug 23 2014 
      GAMCO CIO Howard Ward on Reliable Consumer Stock Ideas Apr 09 2014 
      Assessing the New Boss at National Oilwell Varco Mar 31 2014 


      More From Other Websites
      Business Highlights Feb 25 2015
      Novo Nordisk's Oral Semaglutide Positive in Diabetes Study - Analyst Blog Feb 23 2015
      Novo Nordisk Pops On Successful Diabetes Drug Trial Feb 20 2015
      Baxter Announces Positive Data for BAX 855; Competition Rife - Analyst Blog Feb 12 2015
      On MannKind, Diabetics Have One Up On Wall Street Feb 06 2015
      Novo Nordisk files annual report with the SEC Feb 05 2015
      Sale of Seattle BioMed, Juno building sets Seattle price record Feb 03 2015
      Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Feb 03 2015
      Novo Nordisk's Q4 Earnings Rise Y/Y, Provides 2015 Outlook - Analyst Blog Feb 02 2015
      Diabetics: Use Your Firsthand Experience To Beat Wall Street Jan 30 2015
      Up to Speed: Peltz receives ammo in fight against DuPont (Video) Jan 28 2015
      Afrezza Breathes Life Into MannKind Jan 27 2015
      Novo Nordisk stock rises 3% Jan 26 2015
      4 Stocks Spiking on Unusual Volume: Novo Nordisk and More Jan 26 2015
      Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog Jan 20 2015
      Three Companies That Should Benefit From a Stronger U.S. Dollar Jan 20 2015
      CSE Enjoys Record Year in 2014, International Outreach and Trading Initiatives Help Shape Agenda for... Jan 14 2015
      5 Obesity Stocks Investors Are Watching Jan 14 2015
      Pharma Grows Itself a New Challenge -- Overheard Jan 13 2015
      Overheard: Novo Nordisk’s Weighty Issue Jan 05 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      Gintaras58
      ReplyGintaras58 - 11 months ago
      few excellent prducts to come soon
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK